Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded
- Contract number
- SPE2DB25FRVD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,753
Award facts
- Contract value 100% obligated
- $14,752.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Entyvio 108 mg/0.68 mL pen injectors, with a contract ceiling value of $14,752.92 and an ultimate completion date of October 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026, which enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems through the Defense Logistics Agency. Entyvio is a specialty pharmaceutical product used in the treatment of inflammatory bowel conditions, consistent with the company's portfolio of specialty medications and biologics supplied across multiple therapeutic domains. This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's extensive federal contracting relationship with DLA, reflecting the company's continued role as a primary vendor for military and federal healthcare supply chains.
Quick answers
Who was awarded contract SPE2DB25FRVD8?
SPE2DB25FRVD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FRVD8 worth?
The government has obligated $14,753 on SPE2DB25FRVD8.
Is contract SPE2DB25FRVD8 an order under another contract?
Yes. SPE2DB25FRVD8 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVD8 competed?
The extent of competition for SPE2DB25FRVD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award